Showing 1 - 10 of 103,100
period one treatment adoption is an irreversible act with future, but uncertain, consequences. New information, both … future treatment options if resistant viral strains develop. On the other hand, postponing the introduction of HAART may … resistance effect has no effect on leaves the optimal treatment decision as far as it is high enough. Le bien-fondé d …
Persistent link: https://www.econbiz.de/10005100920
A micro decision-making utility model under uncertainty is presented as a complementary foundation for macro … random output which is a function of the input variable called "treatment" consisting of such elements as social distance …, washing hands, wearing a face mask, and others. The decision maker selects a level of treatment that maximizes her …
Persistent link: https://www.econbiz.de/10013269247
Becker and Murphy, but incorporates uncertainty. We model uncertainty through the Wiener stochastic process. This process …
Persistent link: https://www.econbiz.de/10010798435
Health fluctuations render the outcome of any treatment switch uncertain, so that decision makers might have to wait … for more information before optimally switching treatments. This paper sets up a stochastic model that provides an optimal … rule for the timing of treatment switch. The results of the model were then tested empirically with patient-based data on …
Persistent link: https://www.econbiz.de/10011118532
that the firm may start the regulatory process earlier if regulatory approval is valid long enough or if uncertainty is … longue ou si l'incertitude est assez élevée; autrement elle le retarde. Ces décisions dépendent aussi de la durée de l …
Persistent link: https://www.econbiz.de/10005169015
change and to explain how these estimates are built in order to identify the main sources of uncertainty and approximation … affecting them. Second, the paper discusses how this uncertainty should influence policymaker?s decisions. A main conclusion of …: their irreversibility, and the risk that they are extreme.<P>Évaluer les impacts du changement climatique : Une revue de la …
Persistent link: https://www.econbiz.de/10005046106
A nonparametric Data Envelopment Analysis (DEA) is performed on hospitals in the federal state of Saxony (Germany) and in Switzerland. This study is of interest from three points of view. First, contrary to most existing work, patient days are not treated as an output but as an input. Second,...
Persistent link: https://www.econbiz.de/10010305449
This work follows the series of studies conducted in Ipea, in order to compare the efficiency of the Brazilian health system to health systems of other countries. We evaluate the efficiency of expenditure in health care provision by comparing various output measures (life expectancy; infant...
Persistent link: https://www.econbiz.de/10010330549
We evaluate the efficiency of expenditure in health care provision by comparing various output measures (life expectancy; infant survival rate; years of life recovered from diseases; population; area) from the health system of Brazilian and OECD countries with an expenditure measure (health...
Persistent link: https://www.econbiz.de/10010330615
We evaluate the efficiency of expenditure in health care provision by comparing various output measures (life expectancy; infant survival rate; years of life recovered from diseases; population; area) from the health system of Brazilian, Latina America and Caribbean Countries with an expenditure...
Persistent link: https://www.econbiz.de/10010330667